The ideal enucleation in robot-assisted laparoscopic partial nephrectomy (RAPN) is complete preservation of the parenchyma. However, in reality, a certain amount of parenchyma is damaged during tumor resection or tumor bed reconstruction. The contact surface area (CSA) between the tumor and the parenchyma is a proposed predictor of postoperative renal function, and several studies have reported its validity. We presumed that the effect of the CSA on parenchymal preservation is greater in the enucleation technique than in the standard partial nephrectomy because in the enucleation technique, the effect of resection volume of the normal parenchyma remains minimal. The aim of this study was to evaluate the change in operated parenchymal volume during RAPN limited to the enucleation technique and analyze the predictors of the decrease in operated parenchymal volume, including the CSA.
INTRODUCTION AND OBJECTIVES:
The ideal enucleation in robot-assisted laparoscopic partial nephrectomy (RAPN) is complete preservation of the parenchyma. However, in reality, a certain amount of parenchyma is damaged during tumor resection or tumor bed reconstruction. The contact surface area (CSA) between the tumor and the parenchyma is a proposed predictor of postoperative renal function, and several studies have reported its validity. We presumed that the effect of the CSA on parenchymal preservation is greater in the enucleation technique than in the standard partial nephrectomy because in the enucleation technique, the effect of resection volume of the normal parenchyma remains minimal. The aim of this study was to evaluate the change in operated parenchymal volume during RAPN limited to the enucleation technique and analyze the predictors of the decrease in operated parenchymal volume, including the CSA.
METHODS: The study subjects were 129 patients who underwent RAPN for T1 renal tumors using the enucleation technique. Measurements for parenchymal volume, tumor volume, and CSA were obtained in the venous phase on enhanced CT and calculated using Mimics 20.0 and 3-matic 12.0 (Materialise N.V.). All measurements, such as volumetric and renal function analysis, were performed at <2 months before and 6 months after surgery.
RESULTS: The mean age was 56 years, and the mean tumor size was 33mm. The mean tumor volume was 27 cc, and the mean CSA was 23 cm 2 . In the complete cohort, the mean preoperative and postoperative normal parenchymal volumes for the operated kidney were 158 cc and 142 cc, respectively. The mean change in parenchymal volume in the operated kidney was -10%. In contrast, the mean change in global estimated glomerular filtration was -4.5%. A univariate analysis revealed that RENAL score, CSA, tumor volume, and warm ischemia time were associated with the change in the operated kidney parenchymal volume. However, larger CSA was the only independent predictor of decreased operated parenchymal volume of <10 cc in multivariate analysis.
CONCLUSIONS: The CSA was a strong predictor of the decrease in the parenchymal volume in the operated kidney during RAPN performed using the enucleation technique for T1 renal tumors.
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PRESENCE OF PERITUMORAL PSEUDOCAPSULES DETECTED BASED ON FINDINGS FROM ROBOT-ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR LOCALIZED RENAL CELL CARCINOMA Toshio Takagi*, Kazuhiko Yoshida, Tsunenori Kondo, Junpei Iizuka, Hirohito Kobayashi, Hideki Ishida, Masayoshi Okumi, Yoji Nagashima, Kazunari Tanabe, Tokyo, Japan INTRODUCTION AND OBJECTIVES: Tumor enucleation is expected to preserve more renal parenchyma and avoid damaging renal vessels or the collecting system for hilar tumors by providing a negative surgical margin. Although peritumoral PCs are a landmark for tumor enucleation, all renal tumors were not surrounded by PC. Determining whether or not a PC exists is useful for avoiding a positive cancer margin when tumor enucleation is employed for RAPN; however, there are a few reports discussing the factors associated with the presence/absence of a PC. In the present study, we examined peritumoral PC status in patients with localized RCC who underwent RAPN in relation to patient or tumor characteristics including pathological findings, and carried out a multivariate analysis to identify factors that would allow prediction of the absence of a PC.
METHODS: A total of 367 patients with clinical T1 RCC who underwent RAPN were divided into two groups according to PC status. The groups were compared in terms of patient and tumor characteristics. A PC was defined as present if it completely surrounded the tumor. Four micrometer-thick paraffin sections were stained with hematoxylineosin staining and observed by an authorarized pathologists (YN). Multivariate logistic regression analysis was performed to identify predictive factors for the absence of PC.
RESULTS: Of the 367 tumors, 323 (88%) were surrounded by a METHODS: Data from the National Cancer Database personal use file (NCDB) was used to evaluate trends for patients that underwent surgery to treat T1a kidney cancer. A total of 57,860 patients over the age of 29 with T1a kidney cancer were reported to the NCDB. Statistical analysis was performed to assess the association between patient's age and clinical approach. Patients were excluded if their cancer or demographics did not fit the scope of this analysis, for example, bilateral presentation or metastasis of the tumor. Patients under the age of 30 were excluded due to the small sample size (126 or less per age). Those included in the study were grouped by decade of life, except those over 80, which comprised a single group. Treatment options excluded from the study were local tumor excision, any nephrectomy (simple, subtotal, complete, partial, simple, total, radical) in continuity with the resection of other organs (i.e. colon or bladder), nephrectomy NOS, surgery NOS, and unknown if surgery performed.
RESULTS: NT is less commonly chosen in patients under the age of 80 but was the most common approach for patients 80þ. Rates of NT were 4.12%, 4.46%, 7.50%, 10.25%, 18.08% and 47.89%, respectively among the age groups. Those in the 80þ age group were significantly more likely to undergo no treatment (P<0.001). LTD had significant differences in utilization rate: 3.54%, 4.97%, 7.54%, 11.80%, 16.63% and 19.39%, respectively (P<0.001). PN was significantly less likely to be utilized in patients 80 years or older but was the most common surgical approach for all groups under 80: 73.55%, 69.50%, 63.36%, 56.39%, 44.16%, and 17.46%, respectively (P<0.001). Rates of RN were not significantly different between age groups during this time: 18.79%, 21.07%, 21.60%, 21.56%, 21.13%, 15.26%, respectively. CONCLUSIONS: When controlling for age, patients 80 years or older are more likely to receive no treatment (active surveillance) for T1a kidney tumors, and they are less likely to undergo PN compared to all other age groups. They are no less likely to undergo RN as a treatment option for T1a tumors than any other age group. These results should prompt further evaluation of treatment trends based on age, ensuring the best patient outcomes. METHODS: A retrospective review was performed of all RN performed at our center from 2006-2016. 273 patients with available nuclear renal scan and imaging demonstrating non-metastatic RCC with preoperative GFR >15ml/min/1.73m2 were analyzed. GFR values were estimated by CKD-EPI preoperatively and up to 5 years after RN. Pre and postoperative volumes of the uninvolved kidney were measured by free-hand scripting from axial images at 3 mm intervals. Renal functional compensation was defined: percent change in GFR (postoperative GFR/preoperative GFR of preserved kidney). Renal parenchymal compensation was defined: percent change in parenchymal volume (postoperative volume/preoperative volume of preserved kidney). Multiple regression was used to identify predictive factors of renal compensation.
RESULTS: Median age was 67 and 67% of patients were male. Comorbidities before RN included hypertension in 70%, 28% cardiovascular disease, 26% diabetes, 55% were active/former smokers, and 37% had CKD. Median BMI was 30. Locally advanced (!T3a) tumors were found in 53% and clear cell histology in 71% of cases. Renal functional compensation was observed at 2 weeks (median 110%) and increased during the first 3 months (median 126%) after RN. Functional stability was then observed to 5 years. The median percent increase in renal parenchymal volume at 3-12 months was 10%, but in addition, the functional efficiency per unit of parenchymal volume also increased 10% (GFR units/cm3 of parenchyma was 0.21 preoperatively vs. 0.23
